Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Breast Neoplasms, Male × Temozolomide × 1 year × Clear all

Sponsor

Conditions

Glioblastoma 93 Glioma 36 Brain Neoplasms 21 Neuroblastoma 20 Gliosarcoma 15 Astrocytoma 15 Sarcoma, Ewing 12 Rhabdomyosarcoma 11 Recurrence 10 Medulloblastoma 10 Small Cell Lung Carcinoma 7 Sarcoma 7 Neoplasms 7 Oligodendroglioma 6 Melanoma 6 Ependymoma 6 Diffuse Intrinsic Pontine Glioma 6 Osteosarcoma 5 Prostatic Neoplasms 4 Ovarian Neoplasms 3 Neuroendocrine Tumors 3 Neoplasm Metastasis 3 Lymphoma, Follicular 3 Lymphoma 3 Lung Neoplasms 3 Colorectal Neoplasms 3 Adenoma, Islet Cell 3 Wilms Tumor 2 Somatostatinoma 2 Rhabdoid Tumor 2

Interventions

Taxes 4 Paclitaxel 3 Cyclophosphamide 3 exemestane 2 Tamoxifen 2 Leuprolide 2 Letrozole 2 Immunotherapy 2 Goserelin 2 Doxorubicin 2 Anastrozole 2 trastuzumab biosimilar HLX02 1 romidepsin 1 ribociclib 1 pegfilgrastim 1 entinostat 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 abemaciclib 1 Vitamins 1 Trastuzumab 1 Psychiatric Rehabilitation 1 PF-05280014 1 Ontruzant 1 Omeprazole 1 Ogivri 1 Neoadjuvant Therapy 1 Mental Status and Dementia Tests 1 Lapatinib 1 Indomethacin 1 Immunoglobulin G 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡